Clinical trial
Atomoxetine for the Treatment of Cannabis Dependence
NCT00167297 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00167297 |
|---|---|
| Title | Atomoxetine for the Treatment of Cannabis Dependence |
| Official title | A Pilot Trial of Atomoxetine to Enhance Motivational Interviewing Therapy for the Treatment of Cannabis Dependence |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | University of Pennsylvania |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cannabis Dependence |
| Intervention type | Drug |
| Interventions | Atomoxetine |
| Enrollment | 16 |
| Start date | Nov 1, 2004 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | Jan 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: